
Qiagen/Illumina: Earthquake in NGS IVD market
The announcement of the 15-year partnership of next generation sequencing (NGS) market leader Illumina and QIAGEN came after Illumina cut its 2019...

Cellectis presents way to safer CAR-Ts
The company presented the in vitro "proof-of-concept" of their new CAR-T cells, in which they integrated a gene network that senses tumour...

Polyphor presents AMR breaker
In Nature, Anatol Luther et al. from Polyphor AG and the University of Zurich describe the discovery and characterisation of a new class of...

Researchers identify CTLA-4 response marker
The research team headed by Simon Heideger and Hendrick Poeck from Technical University of Munich together with colleagues from Memorial Sloan...

Microbiota contribute to skin damage in cancer therapy
EGFR inhibitors such as erlotinib interrupt the growth of cancer cells and are approved to treat malignancies such as lung and colorectal cancer....

Successful EFIB in Brussels
More than 260 companies with 480 delegates from 30 countries joined for this year’s “European Forum for industrial Biotechnology and Bioeconomy”...

European circular bioeconomy fund near closing
Hauck & Aufhäuser Fund Services S.A. will act as the Alternative Investment Fund Manager. The ECFB will provide access to equity, debt or...